Financial Performance - The company reported a revenue of CNY 301,841,864.23 for Q1 2022, a decrease of 25.93% compared to the same period last year[4]. - The net profit attributable to shareholders was CNY -11,479,192.95, representing a decline of 116.60% year-over-year[5]. - The net profit after deducting non-recurring gains and losses was CNY -36,468,951.10, down 156.29% from the previous year[5]. - Total operating revenue for Q1 2022 was ¥301,841,864.23, a decrease of 26.0% compared to ¥407,514,538.24 in Q1 2021[29]. - Net profit for Q1 2022 was -¥11,479,192.95, a significant decline from a net profit of ¥73,119,388.12 in Q1 2021[30]. - Total comprehensive income for Q1 2022 was CNY 13,238,945.97, compared to CNY 66,579,841.64 in Q1 2021, reflecting a significant decline[41]. Cash Flow - The company's cash flow from operating activities was CNY -293,729,698.94, a decrease of 1,472.33% compared to the same period last year[4]. - The net cash flow from operating activities decreased by 1,472.33%, mainly due to reduced sales receipts and increased payments for goods and employee compensation[13]. - Cash flow from operating activities showed a net outflow of -¥293,729,698.94, contrasting with a net inflow of ¥21,403,658.96 in Q1 2021[34]. - The company reported a total cash outflow from operating activities of CNY 616,521,785.75 in Q1 2022, compared to CNY 336,153,805.43 in Q1 2021, indicating an increase of approximately 83.5%[42]. - Cash inflow from investment activities was ¥1,005,429,428.72, compared to ¥474,071,028.75 in the previous year, marking a substantial increase[34]. - Cash inflow from investment activities in Q1 2022 was CNY 1,001,911,116.53, up from CNY 469,320,281.80 in Q1 2021, representing an increase of approximately 113.4%[42]. Research and Development - Research and development expenses totaled CNY 86,170,679.39, an increase of 66.57% year-over-year, accounting for 28.55% of revenue, up 15.86 percentage points[5]. - Total R&D investment increased by 66.57%, driven by an increase in personnel for AC/DC and DC/DC product development and related stock-based compensation expenses[13]. - Research and development expenses rose to ¥86,170,679.39, an increase of 66.7% compared to ¥51,732,958.65 in Q1 2021[29]. - Research and development expenses for Q1 2022 were ¥54,096,863.39, an increase of 16.2% compared to ¥46,448,445.52 in Q1 2021[39]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 7,437[15]. - The top shareholder, Hu Liqiang, holds 16,564,500 shares, accounting for 26.70% of the total shares[15]. - The second-largest shareholder, Xia Feng, holds 15,115,500 shares, representing 24.37% of the total shares[15]. - The company plans to grant 732,000 restricted stocks at a price of 86.00 CNY per share as part of its 2021 incentive plan[17]. - The company intends to grant 1,155,376 restricted stocks at a price of 113.80 CNY per share under its 2022 incentive plan[19]. - The company has implemented a stock incentive plan to motivate and retain key personnel[19]. Assets and Liabilities - The total assets at the end of the reporting period were CNY 2,848,505,609.41, a 1.64% increase from the end of the previous year[5]. - The company's total assets increased slightly to ¥2,848,505,609.41 from ¥2,802,619,783.71, reflecting a growth of approximately 1.6%[26]. - The total current assets decreased to ¥1,719,172,221.98 from ¥2,013,969,901.43, indicating a decline of about 14.6%[26]. - The total current liabilities rose to ¥825,664,801.43 from ¥806,117,686.48, marking an increase of about 2.9%[27]. - The company's non-current liabilities decreased to ¥82,414,015.82 from ¥89,545,833.12, showing a reduction of approximately 7.9%[27]. - The company's inventory increased to ¥474,711,846.22 from ¥390,839,450.51, representing a growth of approximately 21.5%[26]. Market and Operational Challenges - The company faced operational uncertainties due to the impact of COVID-19, with upstream suppliers experiencing capacity constraints and logistics issues in Shanghai[23]. - The company decided to terminate the acquisition of 95.75% equity in Lingou Chuangxin due to significant changes in the market environment, which was initially planned to be completed in 2021[21]. Earnings Per Share - The company reported a basic earnings per share of -¥0.19 for Q1 2022, down from ¥1.12 in Q1 2021[31]. - Basic earnings per share for Q1 2022 were CNY 0.21, down from CNY 1.08 in Q1 2021, indicating a decrease of approximately 80.6%[41].
晶丰明源(688368) - 2022 Q1 - 季度财报